Source:http://linkedlifedata.com/resource/pubmed/id/11759823
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-12-10
|
pubmed:abstractText |
Serum levels of MUC1 and antibodies (Abs) against MUC1 (IgG and IgM-MUC1) were evaluated in healthy women related to pregnancy and lactation status. A total of 149 serum samples were obtained from: nulliparous, primiparous pregnant, multiparous pregnant that have lactated, multiparous pregnant without lactation, multiparous non-pregnant actual lactating, multiparous non-pregnant that have lactated and finally, multiparous non-pregnant women without lactation. In all assays, we included pre- and post-serum samples belonging to a breast cancer patient vaccinated with a MUC1 derived peptide. CASA test was employed to measure MUC1 while IgG- and IgM-MUC1 serum Abs were evaluated with an ELISA using a 100 mer peptide as catcher. In all groups, mean IgM levels were higher than IgG mean values; when samples were grouped in pregnants versus non-pregnants, a significant difference was detected with both Abs, being raised in non-pregnants. When samples were grouped in lactating versus non-lactating a significant difference was detected with IgG-MUC1, being raised in lactating women while no significant difference was found with IgM-MUC1. The evaluation of serum MUC1 levels confirmed previous results since a significant difference between pregnant versus non-pregnant groups was found while lactating versus non-lactating samples did not. CONCLUSIONS: (i) Increased MUC1 serum levels are apparently associated with pregnancy but not with lactation; (ii) MUC1 Abs are mainly associated with lactation and with non-pregnant status. These results may be considered a contribution on studies about protection against breast cancer induced by pregnancy and lactation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0167-6806
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-11
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11759823-Adult,
pubmed-meshheading:11759823-Antibody Formation,
pubmed-meshheading:11759823-Breast Neoplasms,
pubmed-meshheading:11759823-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:11759823-Female,
pubmed-meshheading:11759823-Humans,
pubmed-meshheading:11759823-Immunoglobulin G,
pubmed-meshheading:11759823-Immunoglobulin M,
pubmed-meshheading:11759823-Lactation,
pubmed-meshheading:11759823-Middle Aged,
pubmed-meshheading:11759823-Mucin-1,
pubmed-meshheading:11759823-Parity,
pubmed-meshheading:11759823-Pregnancy
|
pubmed:year |
2001
|
pubmed:articleTitle |
Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women.
|
pubmed:affiliation |
Comisión de Investigaciones Científicas de la Provincia de Buenos Aires, Argentina.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|